Expert Columns & Interviews

New Data and Insights on the L74V Resistance Mutation Recent data shed new light on the L74V reverse transcriptase resistance mutation: its mechanism of action, effect on HIV fitness, mutational interactions, and more.
Experts And Viewpoints, June 09, 2005
HIV RT & Entry Inhibitors: Interview With Dr. Daniel Kuritzkes Learn how recent data on RTIs and entry inhibitors affect the current and future treatment of HIV disease.
Experts And Viewpoints, May 13, 2005
Clinical Pharmacology of HIV Therapy: Interview w/Dr. David Back Interest in this field has grown in tandem with the recognition of pharmacologic issues that must be addressed in order to optimize antiretroviral therapy and overall patient care. Learn more here.
Experts And Viewpoints, May 12, 2005
HIV/Hepatitis Coinfections: Interview With Dr. David Thomas Coinfection with hepatitis C virus or hepatitis B virus occurs often in people with HIV, and the presence of dual infection has important implications for treatment of both infections.
Experts And Viewpoints, May 10, 2005
Investigational ART Strategies: Interview With Dr. John Bartlett A significant challenge facing today's HIV clinician is the need to balance the risks for HIV disease progression against adverse events associated with long-term HAART. Learn more here.
Experts And Viewpoints, May 10, 2005
ART and CV Risk: An Expert Interview With Rick Elion, MD Management of cardiovascular and metabolic risks has emerged as a critical task for HIV specialists. Learn the latest about this topic from a clinical expert.
Experts And Viewpoints, March 15, 2005
ART Drug Interactions: Expert Interview w/ Dr. Corky Steinhart From CROI 2005: Learn more about the latest data on drug interactions that are key to the clinical care of HIV-infected patients.
Experts And Viewpoints, March 04, 2005
RESIST-1 Trial & Implications for HIV Therapy: Expert Interview Tipranavir is shaping up to be one of the key components of HIV salvage therapy. Read 4 expert opinions on results from the RESIST-1 study, the most recent comparative trial of this agent.
Experts And Viewpoints, December 29, 2004
The NEAT Study -- A Canadian Perspective Determination of the optimal role of fosamprenavir in HIV therapy will likely require more data from the "real world."
Experts And Viewpoints, December 28, 2004
NRTI Combinations: An Expert Interview With Charles Farthing, MD Medscape HIV/AIDS spoke with Charles Farthing, MD, about current data and opinion regarding how best to use and combine NRTIs in initial therapy, and which combinations to avoid.
Experts And Viewpoints, December 23, 2004
Invasive Aspergillosis: Expert Interview With Thomas Patterson Medscape talks with Thomas Patterson, MD, about what's new, what's needed, and what the future might bring to the challenge of effective therapy for invasive aspergillosis.
Experts And Viewpoints, December 20, 2004
Treatment Simplification: An Expert Interview With Cal Cohen, MD Successful therapy means more than just an undetectable viral load. Medscape talks with Cal Cohen, MD, about approaches to improving antiretroviral therapy for patients with virologic suppression.
Experts And Viewpoints, December 20, 2004
ART Access in the Developing World: Interview w/Dr. David Cooper Access to affordable antiretroviral therapy was one of the most talked about topics at the XV International AIDS Conference. Read the perspective of one leader in the AIDS field here.
Experts And Viewpoints, August 13, 2004
HIV Prevention From PREP to PEP: An Interview w/ Dr. Myron Cohen With a vaccine currently out of reach, HIV prevention strategies -- those that utilize both behavioral and medical interventions -- remain the most important tools available to curtail the epidemic.
Experts And Viewpoints, August 02, 2004
Prevention of MTCT: Interview With Dr. Marc Lallemant From Intl AIDS Conf '04: Read a leading expert's view of the most recent data concerning regimens to prevent mother-to-child transmission of HIV.
Experts And Viewpoints, August 02, 2004
Immune-Based Therapies for HIV: An Interview With Dr. Jay Levy From the XV International AIDS Conference: Read one expert's views on the latest data in the critical area of immune-based therapies for HIV disease.
Experts And Viewpoints, August 02, 2004
Advances in ART Strategies: Expert Interview w/ Rick Elion, MD From the XV International AIDS Conference, read this expert's view of new data on antiretroviral drugs and the implications for current clinical practice.
Experts And Viewpoints, July 29, 2004
Induction/Maintenance Strategies: Interview w/ Peter Ruane, MD The XV International AIDS Conference offered new insights into simplified maintenance regimens after induction therapy with HAART. Read one expert's view of the data here.
Experts And Viewpoints, July 29, 2004
Antiretroviral Pharmacology: Expert Interview w/Dr. David Burger With the large number of antiretroviral regimens now available for the treatment of HIV, clinical pharmacology has become one of the most critical areas of AIDS research.
Experts And Viewpoints, July 27, 2004
NRTIs and ART Regimens: Expert Interview With Dr. Joel Gallant From IAC 2004: Selection of the appropriate NRTI backbone for initial antiretroviral therapy remains an important decision point for HIV clinicians. Read one expert's views on the latest data here.
Experts And Viewpoints, July 26, 2004

No Results